Arun Anand

Arun Anand, MD, serves as Ex-Member of the Board of Directors at Immuneel Therapeutics Pvt. Ltd. since April 2022 and as Chief Operating Officer at Immuneel Therapeutics from August 2019 to August 2024, focusing on improving access to cell and gene therapies for cancer and rare diseases in India. Prior experience includes senior roles at Dr. Reddy's Laboratories from June 2011 to July 2019, where responsibilities encompassed strategic management of the biologics portfolio, development of clinical strategies, and oversight of regulatory access for biosimilars. Additional expertise was gained at Biocon Ltd. leading clinical development for biologics in oncology and immunology, and as Asst Director of Translational Research at Massachusetts General Hospital, emphasizing gynecologic cancers. Educational qualifications comprise an MD from St. John's Medical College, alongside executive education credentials from prestigious institutions including Columbia Business School, Harvard Business School, and MIT Sloan School of Management.